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ABSTRACT
Objective: Despite epidemiologic data showing an increased stroke incidence in African ancestry pop-
ulations, genetic studies in this group have so far been limited, and there has been little characterization
of the genetic contribution to stroke liability in this population, particularly for stroke subtypes.
Methods: We evaluated the evidence that genetic factors contribute to stroke and stroke sub-
types in a population of 917 African and African Caribbean stroke cases and 868 matched con-
trols from London, United Kingdom. We (1) estimated the heritability of stroke in this population
using genomic-relatedness matrix-restricted maximum likelihood approaches, (2) assessed loci
associated with stroke in Europeans in our population, and (3) evaluated the influence of genetic
factors underlying cardiovascular risk factors on stroke using polygenic risk scoring.
Results: Our results indicate a substantial genetic contribution to stroke risk in African ancestry
populations (h2 5 0.35 [SE 5 0.19], p 5 0.043). Polygenic risk scores indicate that cardiovas-
cular risk scores contribute to the genetic liability (odds ratio [OR] 1.09 [95% confidence interval
(CI) 1.01–1.17], p 5 0.029) and point to a strong influence of type 2 diabetes in large vessel
stroke (OR 1.62 [95%CI 1.19–2.22], p5 0.0024). Single nucleotide polymorphisms associated
with ischemic stroke in Europeans shared direction of effect in SLESS (p 5 0.031), suggesting
that disease mechanisms are shared across ancestries.
Conclusions: Stroke in African ancestry populations is highly heritable and influenced by genetic
determinants underlying cardiovascular risk factors. In addition, stroke loci identified in Euro-
peans share direction of effect in African populations. Future genome-wide association studies
must focus on incorporating African ancestry individuals. Neurol Genet 2017;3:e142; doi:
10.1212/NXG.0000000000000142
GLOSSARY
AS 5 all stroke; CE 5 cardioembolic; CHD 5 coronary heart disease; CI 5 confidence interval; GREML 5 genomic-related-
ness matrix-restricted maximum likelihood; GRS 5 genetic risk score; GWAS 5 genome-wide association studies; HDL 5
high-density lipoprotein; IS 5 ischemic stroke; LVD 5 large vessel disease; OR 5 odds ratio; SLESS 5 South London
Ethnicity and Stroke Study; SNP 5 single nucleotide polymorphism; SVD 5 small vessel disease; T2D 5 type 2 diabetes;
TG 5 triglyceride.
Genome-wide association studies (GWAS) of cardiovascular diseases and their risk factors have
greatly improved our understanding of their underlying causes. However, to date, studies in
European ancestry populations have vastly eclipsed those in other populations. African and ad-
mixed African and European populations have been particularly neglected, despite the increased
burden of cardiovascular diseases such as stroke,1 coronary heart disease (CHD), and type 2
diabetes (T2D) in these populations.2,3 Stroke, in particular, has higher incidence and mortality
in African ancestry populations4,5; there is evidence that stroke incidence is decreasing in whites,
but not in blacks.6 There is, therefore, considerable motivation for identifying the genetic
component to stroke in African ancestry populations. One previous GWAS meta-analysis of
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1,592 African American stroke cases from pro-
spective cohorts totaling 14,746 individuals
focused on the broad phenotypes of all stroke
(AS), both ischemic and hemorrhagic, and of
ischemic stroke (IS) alone.7 However, IS itself
represents a syndrome which can be caused by
many different pathophysiologic processes,
with different genetic architectures reported
for the 3 major IS subtypes: cardioembolic
(CE), large vessel disease (LVD), and small
vessel disease (SVD) stroke.8 As most stroke
loci identified to date have been found to
confer risk for specific stroke subtypes,9,10
characterizing the ancestry-specific genetic
component of each of the stroke subtypes is
of interest.
Barriers to performing GWAS in African
ancestry populations until now have included
the following: (1) the lack of suitable reference
panels to adequately characterize and account
for population differences in African popula-
tions and (2) the lack of suitable genotyping
arrays that include appropriate single nucleo-
tide polymorphisms (SNPs) for these popula-
tions. With the release of 1000 Genomes
phase 3, which includes multiple African
ancestry populations for the first time, and
the development of cross-ancestry genotyping
arrays, these barriers have now been removed.
We undertook genome-wide analyses of
stroke and stroke subtypes in a population of
black African and black African Caribbean in-
dividuals from London, United Kingdom, to
identify genetic risk factors associated with
stroke in this minority population. We
estimated the heritability of stroke in this pop-
ulation and evaluated the evidence that SNPs
associated with stroke in Europeans also influ-
ence risk in African ancestry individuals. In
addition, we performed a genetic risk score
(GRS) analysis to identify the contribution
of genetic factors underling cardiovascular risk
factors to the burden of stroke in this ethnic
group.
METHODS Cohort characteristics. The cohort has been
previously described in detail.11 Black patients with stroke were
consecutively recruited from South London, United Kingdom.
Three acute hospitals which cover a neighboring geographical
region (Guy’s and St Thomas’ Hospitals, King’s College Hospital,
and St George’s Hospital) were used to recruit patients between
1999 and 2010. All hospitals have a specialized stroke unit and
a rapid-access TIA clinic. The ethnicity of participants was defined
according to the 2001 definition derived from the UK Census.
Participants were classified as black African or black African
Caribbean.12
Recruitment of controls was by random selection from gen-
eral practice lists in the catchment areas of St George’s, Guys
and St Thomas, and King’s College Hospital NHS Trusts
between 1999 and 2012. In addition, posters inviting healthy
black African and black African Caribbean individuals were dis-
played in local leisure centers, general practice surgeries, churches,
and community centers within a catchment area that included the
London Borough of Wandsworth. Using community-based con-
trols from the same catchment area as cases reduced the risk of
selection bias, by ensuring that they were representative of the
population producing cases. Inclusion criteria comprised self-
reported “Black Caribbean” or “Black African” ethnicity and
being free of clinical cerebrovascular disease.
In both cases and controls, risk factors were collected on
a standard proforma, and blood pressure and body mass index
were measured. A single consultant stroke neurologist (H.S.M.)
derived Trial of Org 10172 in Acute Stroke Treatment (TOAST)
subtypes for all patients.13 These were derived from data collected
on the standard proforma as well as from review of all original
brain imaging in all patients, combined with review of clinical
notes, as appropriate. The presence of hypertension and diabetes
was not used as a criterion in the diagnosis of TOAST subtypes to
avoid any bias resulting from different risk factor prevalences.
Patients with other determined causes of stroke, such as sickle
cell disease, dissection, or vasculitis, were excluded from the
study. Where patients had previous stroke, subtyping was per-
formed on the current stroke. The presence of intracranial steno-
sis was determined by CT angiography or magnetic resonance
angiography, where performed. Stenosis of greater than 50% in
the arterial territory of the stroke was used as a criterion for
determining intracranial stenosis as the pathophysiologic cause.
Standard protocol approvals, registrations, and patient
consents. The study protocol had ethics approval (Wandsworth
Local Research Ethics Committee), and informed consent was
obtained from all participants.
Genotyping and quality control. Study participants from
whom blood samples were obtained and who had consented to
the study were included in the genetic analysis. DNA was ex-
tracted from blood in all samples. Data were genotyped at the
Institute of Psychiatry, Psychology & Neuroscience BRC Ge-
nomics Facility on the Illumina Multi-Ethnic Genotyping
Array (MEGA). SNPs were removed with excess missingness
(.3%), deviation from Hardy-Weinberg equilibrium (p , 1e-
6), or low minor allele frequency (,0.005). Individuals with
excess missingness (.3%), low or high levels of heterozygosity,
relatedness (pi-hat . 0.1875), and discordant phenotypic/genotypic
sex information were removed. All quality control was performed
using PLINK v1.90b2r. Principal components were calculated in
combination with individuals from 1000 Genomes phase 3
populations using smartpca (EIGENSTRAT) on an LD-pruned
subset of the data. Data were imputed to 1000 Genomes phase 3
reference set using SHAPEIT (v2.r778) (for phasing) and impute2
(v2.3.0) (for imputation). Prior to imputation, strand ambiguous
SNPs (A/G and C/T) were removed.
Heritability of stroke in an African ancestry population.
We used GREML (genomic-relatedness matrix-restricted
maximum likelihood) approaches, implemented in the GCTA
package,14,15 to evaluate the proportion of stroke trait variance
(or SNP heritability) explained by genetic factors in SLESS.
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Briefly, the approach estimates the distant relatedness between all
individuals in a data set and uses linear mixed models to estimate
the proportion of trait variance explained by excess distant
relatedness between cases compared to controls. As our sample
size was limited, we restricted our analysis to the phenotype of AS
vs controls. We included 10 ancestry-informative principal
components to control for population structure and used the
estimated population prevalence of stroke for England (2.3%)
from a recent report.16 We removed individuals with distant
relatedness above a threshold of 0.05.14 Analyses were
performed using GCTA version 1.26.0.
Cardiovascular risk factors GRS. We identified SNPs associ-
ated with T2D, lipids, blood pressure, and CHD in populations
of African or admixed African/European ancestry from recent pub-
lications.17–21 Thirty-one associations were identified (table e-1 at
Neurology.org/ng); 7 for blood pressure, 2 for CHD, 16 for lipid
levels (high-density lipoprotein [HDL], low-density lipoprotein, and
triglycerides [TG]); and 6 for T2D. However, one SNP (chr11:
116799496, associated with HDL) was rare and not well imputed
in our data set. A second SNP, rs326, was associated with HDL and
TG, so was only included once. In total, 29 SNPs were included in
the risk score. We generated a risk score for each case and control in
our population by summing the genotype dosage (between 0 and 2)
of trait-increasing SNPs for all variants. The exception was for SNPs
associated with HDL, for which we assumed trait-increasing SNPs
would have a protective effect, and therefore coded them as such in
the risk score. We tested association of the risk score with stroke
using logistic regression, including 10 ancestry-informative principal
components as covariates. Our primary analysis was for the
phenotype of AS against controls—we used a p value of 0.05 to
assess significance in this analysis. After assessing this, we performed
analyses for each of the IS subtypes, and for intracerebral
hemorrhage, and explored associations with the different traits that
composed of the 31 SNP risk score. Analyses were performed using
R Statistical Software (version 3.2.2).
European stroke-associated SNPs in an African ancestry
population. We identified SNPs that have been associated at
genome-wide significance with stroke and stroke subtypes from
recent large-scale meta-analyses and evaluated them in SLESS
in the subtype in which they were originally identified.9,10,22–24
Association analysis was performed on imputed genotype dosages
using PLINK v1.90b2r, including age, sex, and the first 10
principal components as covariates.
RESULTS Cohort characteristics are presented in
table 1. Across the SLESS study, 95.3% had a CT,
47.8% had an MRI, 98.6% had an ECG, 51.3% had
an echocardiogram, and 96% had extracranial vessel
imaging. Intracranial imaging was performed in
40.5% of patients, with intracranial stenosis found
in 20.1% of patients.
One thousand eight hundred ninety-seven individu-
als were genotyped in total. After quality control proce-
dures, there were 917 stroke cases and 868 controls, all
of black African or black African Carribean ancestry.
The majority of cases were black African Carribean
(63.9%). The mean age in cases was 65.0 years (SD
13.1). The mean age was similar across ischemic
subtypes but lower for intracerebral hemorrhage
(57.9 years [SD 13.7]).
Population structure. We used principal component
analysis, implemented in EIGENSTRAT to charac-
terize the genetic ancestry of SLESS individuals,
merging them with 1000 Genomes phase 3 samples
for comparison, which includes African populations
from Kenya, Nigeria, Sierra Leone, and Gambia;
and African Caribbean populations from Barbados.
There were differences in ancestry-informative
principal components between SLESS black African
and black African Caribbean individuals, with more
European admixture in black African Caribbean
individuals (PC1; p 5 3.7 3 10218) as might be
expected given the demographic history of the
Caribbean region. Principal component 6 broadly
separated African populations by geographical
location from East to West. We saw more
segregation of SLESS black African samples with
East African samples from 1000 Genomes. To
ensure that population structure was adequately
controlled for by including the first 10 principal
components, we performed genome-wide
association analyses in each phenotype, assessed
the genomic inflation factor, and plotted QQ
plots. In each analysis, inflation was well
controlled (l , 1.02), indicating that inflation
due to population structure was well controlled
(figures e-1–e-5).
Table 1 Cohort characteristics
Phenotype N Age, y, mean (SD) % Male % HT % Diabetes % HL % AF % IHD
All stroke 917 65.0 (13.1) 58.1 85.1 41.7 58.7 13.1 11.7
All intracerebral hemorrhage 109 57.9 (13.7) 66.1 90.7 24.3 52.4 3.7 4.7
All ischemic stroke 808 66.0 (12.8) 57.1 84.3 44.2 59.5 14.4 12.6
Cardioembolic ischemic stroke 173 67.9 (14.1) 60.1 78.5 37.2 55.6 56.7 27.5
Large artery ischemic stroke 102 64.4 (11.5) 59.8 85.1 46.5 68.4 0.0 9.1
Small vessel ischemic stroke 271 65.8 (11.1) 55.7 90.6 46.8 62.8 1.5 7.6
Controls 868 58.7 (12.0) 52.1 52.9 18.0 34.9 NA 3.9
Abbreviations: AF 5 atrial fibrillation; HL 5 hyperlipidemia; HT 5 hypertension; IHD 5 ischemic heart disease; NA 5 data
not recorded.
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Heritability of stroke in an African ancestry population.
We next estimated the heritability of stroke in SLESS
using GREMLmethods. With a relatedness threshold
of 0.05 (equivalent to second-cousin relatedness), 161
individuals were removed (89 cases, 72 controls).
We detected a genetic contribution to AS in SLESS
Figure 1 Association of genetic risk scores derived from cardiovascular risk factors with stroke phenotypes
in the South London Ethnicity and Stroke Study
(A) All stroke. (B) Ischemic stroke. (C) Intracerebral hemorrhage. (D) Cardioembolic. (E) Large vessel disease. (F) Small vessel disease.
*p, 0.05; AS5 all stroke; BP5 blood pressure; CHD5 coronary heart disease; ICH5 intracerebral hemorrhage; IS5 ischemic
stroke; LVD 5 large vessel disease; Overall 5 all risk factors combined; SVD 5 small vessel disease; T2D 5 type 2 diabetes.
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(p 5 0.043). Assuming a population prevalence of
2.3%, we estimate heritability to be 0.35 (SE 0.19).
If the prevalence were assumed to be higher (4%),
this estimate would rise to 0.41 (SE 0.23); whereas for
a lower prevalence (1%), the estimate is 0.26 (SE
0.16). This compares to a heritability estimate of
0.18 in the largest analysis in Europeans to date.8
Cardiovascular risk factor GRS. The GRS capturing
SNPs associated at genome-wide significance in
African ancestry populations with T2D, CHD,
blood pressure, and lipid levels was associated with
AS (odds ratio [OR] 1.09 [95% confidence interval
(CI) 1.01–1.17], p 5 0.029), with a slightly
stronger association in IS (OR 1.10 [95% CI 1.02–
1.18], p5 0.017, figure 1). Conversely, the risk score
was not associated with intracerebral hemorrhage
(OR 0.99 [95% CI 0.85–1.15], p 5 0.89). We
next explored the association of the risk score with
IS subtypes. There was an association with SVD (OR
1.14 [95% CI 1.03–1.27], p5 0.016) and LVD (OR
1.18 [95% CI 1.01–1.39], p 5 0.041) but not CE
(OR 1.04 [95% CI 0.92–1.18], p 5 0.51). In LVD,
the association was driven by a strong association with
T2D SNPs (OR 1.62 [95% CI 1.19–2.22], p 5
0.0024).
European stroke-associated SNPs in an African ancestry
population. All 6 associations with IS or IS subtypes in
Europeans shared the same direction of effect in
SLESS (p 5 0.031 from binomial test). However,
none of the SNPs associated with stroke or stroke
subtypes in Europeans were associated with stroke
in SLESS (table 2). For most of the SNPs, allele
frequencies were similar in European populations
and in SLESS. A notable exception was rs10744777
(12q24.12), which was much rarer in SLESS (fre-
quency of T allele 5 0.05) than in Europeans (fre-
quency of T allele 5 0.68). Frequencies of all SNPs
were comparable to those from matched reference
populations.25 One SNP, rs4471613, was reported
to be associated with stroke in an African American
population at genome-wide significance, albeit
without replication.7 We found no evidence that
this locus was associated with stroke in SLESS (OR
1.05 [95% CI 0.62–1.77]; p 5 0.85).
DISCUSSION We performed genome-wide analyses
to characterize the genetic contribution to stroke in
black African and black African Caribbean
individuals from the local population in London,
United Kingdom. Our results provide novel insights
into the genetic contribution to stroke in this
population. First, they indicate that genetic factors
are a contributor to stroke liability in this ethnic
group. Our estimate of SNP heritability was greater
than that observed in the largest such analysis in
Europeans,8 which might indicate a stronger
influence of genetics in this population. However,
our estimate lacked precision, reflecting the small
sample sizes; therefore, a much larger sample would
be required to determine this increase conclusively.
Second, our results show that the genetic component
to cardiovascular risk factors such as T2D, CHD,
lipid levels, and hypertension contributes to stroke
risk in this population. This mirrors findings in
European ancestry populations26,27 and therefore
indicates similarities in underlying risk factors across
populations. The risk score was most strongly
associated with the LVD and SVD subtypes of
stroke—and in LVD, this was driven by a strong
association with T2D, for which there is an
increased burden in this population.28 Our results
might, therefore, suggest a particularly strong
influence of T2D on LVD in this population. In
addition, the direction of effect of the association of
a lipid GRS with LVD was in the opposite direction
to what might be expected. Given the small number
of LVD cases in our analysis (N 5 109), further
replication of these findings is warranted. Third, we
investigated SNPs previously reported as being
Table 2 Association of SNPs associated with stroke from European population in SLESS
SNP Gene Phenotype RA OA OR (95% CI) (SLESS) OR (95% CI) (EUR) p Value Freq (EUR) Freq (SLESS) Same direction
rs532436 ABO IS A G 1.09 (0.86–1.38) 1.09 (1.05–1.12)26 0.68 0.19 0.1 Y
rs10744777 12q24.12 IS T C 1.18 (0.83–1.66) 1.10 (1.06–1.13)22 0.36 0.68 0.05 Y
rs2107595 HDAC9 LVD A G 1.26 (0.87–1.81) 1.39 (1.27–1.53)23 0.19 0.16 0.19 Y
rs12122341 TSPAN2 LVD G C 1.13 (0.66–1.92) 1.18 (1.12–1.25)9 0.66 0.26 0.12 Y
rs6843082 PITX2 CE G A 1.10 (0.84–1.42) 1.36 (1.27–1.47)10 0.48 0.21 0.33 Y
rs879324 ZFHX3 CE A G 1.16 (0.83–1.63) 1.25 (1.15–1.35)10 0.39 0.19 0.14 Y
rs2984613 PMF1-BGLAP ICH C T 0.81 (0.58–1.12) 1.24 (1.09–1.40)24 0.19 0.68 0.75 N
Abbreviations: CE 5 cardioembolic; CI 5 confidence interval; EUR 5 European ancestry analyses; ICH 5 intracerebral hemorrhage; LVD 5 large vessel
disease; OA 5 other allele; OR 5 odds ratio; RA 5 reference allele; SLESS 5 South London Ethnicity and Stroke Study; SNP 5 single nucleotide poly-
morphism.
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associated with stroke, mostly from European-only
analyses, in SLESS. Although no individual SNP
was significant, all IS associations were in the same
direction of effect, suggesting that disease
mechanisms are likely to be shared across ancestries.
This study has limitations. Our sample size (917
cases and 868 controls) was relatively limited for
GWAS, meaning that we were unable to calculate
heritability of stroke in disease subtypes. The low
sample size for these analyses meant that the GCTA
algorithm did not converge. Larger studies will be
required to perform these analyses and to formally
compare estimates of heritability between different
ancestral populations. Our GRS were based on SNPs
identified in studies to date in African ancestry popu-
lations. As studies in African ancestry populations
grow larger, more SNPs will be identified, and this
will no doubt influence the results from an equivalent
analysis. In all analyses, we grouped black African and
black African Caribbean individuals together to
increase power. Risk factor profiles differ in these 2
populations, which might modulate the influence of
genetics on risk of stroke in the 2 groups. We were
underpowered to assess these differences. However,
the GRS results for AS were not significantly different
in the African Caribbean subgroup to the overall re-
sults (OR 1.05 [95% CI 0.97–1.14] compared to
OR 1.09 [95% CI 1.01–1.17]), which might point
to similarities between the groups. A single individual
performed AS subtyping. This is a common approach
in genetic studies of stroke; although intraobserver
agreement has been shown to be relatively high,
there remains some potential for consistent
misclassification.
As loci identified in GWAS increase in number,
the priority in complex disease research will move
to interpreting associated loci and identifying the
causal variants. African ancestry populations will per-
form a vital role in this exercise as, due to the lower
linkage disequilibrium in these populations, fine
mapping techniques can be more successfully used,29
which will help to identify which specific variants are
associated with disease. This population, and the re-
sults obtained from these analyses, will help to guide
such future multiethnic genetic studies in stroke.
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